E215: The Pursuit of Uncorrelated Returns in Venture Capital w/Dan Kimerling
Can venture capital be reinvented to deliver alpha without relying on “heroic assumptions”? In this episode, I go deep with Daniel Kimerling, Founder and Managing Partner of Deciens Capital, on his mission to build a different kind of venture fund—one focused on highly concentrated, long-duration bets in financial…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from How I Invest with David Weisburd
See all episodes →
36%E451: Peter Thiel's 27-Year Partner on the AI Bubble, the Venture Capital Crisis, and the PayPal Mafia
36%E449: Federated Hermes CEO on $400 Billion in Cash, the Private Markets Boom, and AI
34%E454: True Anomaly’s Even Rogers on Space Warfare, China’s Military Advantage, and the Defense Tech Boom
Similar episodes from other shows
More like How I Invest with David Weisburd →
20VC: The Most Powerful Investor You Might Not Know | Why The Distinction Between Public vs Private is BS | The Misalignments Between GPs and their LPs | Portfolio Construction 101: Diversification, Capital Concentration, Loss Rates with Peter Singlehurst
60%Felicis founder Aydin Senkut: why moats are dead and alive
How to Think About Alternatives with JPMorgan's Alternative Asset Management CIO Paul Zummo
D.A. Wallach Explains Why Biotech VC Is So Different
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.